Viewing Study NCT00698932


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-02 @ 7:16 AM
Study NCT ID: NCT00698932
Status: COMPLETED
Last Update Posted: 2011-09-21
First Post: 2008-06-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-06
Start Date Type: None
Primary Completion Date: 2009-10
Primary Completion Date Type: ACTUAL
Completion Date: 2009-10
Completion Date Type: ACTUAL
First Submit Date: 2008-06-16
First Submit QC Date: None
Study First Post Date: 2008-06-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-09-20
Results First Submit QC Date: None
Results First Post Date: 2011-09-21
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-08-17
Last Update Post Date: 2011-09-21
Last Update Post Date Type: ESTIMATED